SXT and Taxo A Disks for Presumptive Identification of Group A and B Streptococci in Throat Cultures
A bacitracin (0.04 units, BBL)-SXT (trimethoprim, 1.25 mg, plus sulfamethoxazole, 23.75 mg, BBL) susceptibility test was 94% accurate in presumptively identifying streptococci as either group A, B or not group A and B.
Uloženo v:
| Vydáno v: | J Clin Microbiol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology (ASM)
1976
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC274426/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/965480/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.4.2.192-193.1976 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|